InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Fox Jonathan C. Officer active across 1 company, notably Edgewise Therapeutics, Inc.. In total, 7 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €264k. Activity tracked since 26 December 2023. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Fox Jonathan C is a declarant linked to Edgewise Therapeutics, Inc., where he is a Director. Across 7 filings in total, the 7 sampled filings cover the period from 2023-12-28 to 2026-04-03, with EUR 264147 of buys and EUR 0 of sells, and the modal transaction nature is Attribution.